241 related articles for article (PubMed ID: 6100051)
1. Passive immunization against varicella in sick neonates by transfusion from donors immunologically enhanced by previous vaccination with live varicella vaccine.
Isomura S; Nagai H; Kuroyanagi M; Horizawa S; Takahashi M
Biken J; 1984 Sep; 27(2-3):133-6. PubMed ID: 6100051
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
Naganuma Y; Osawa S; Takahashi R
Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
[TBL] [Abstract][Full Text] [Related]
3. Varicella infection in a children's hospital: prevention by vaccine and an episode of airborne transmission.
Tsujino G; Sako M; Takahashi M
Biken J; 1984 Sep; 27(2-3):129-32. PubMed ID: 6100050
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
[TBL] [Abstract][Full Text] [Related]
5. Prevention of varicella in immunocompromised patients on unpredictable occurrence of the disease in a children's ward: vaccine-boostered immune whole blood transfusion (VIB) method.
Hirao T
Biken J; 1984 Sep; 27(2-3):137-41. PubMed ID: 6100052
[TBL] [Abstract][Full Text] [Related]
6. Prevention of varicella in urgent cases by passive transfer of vaccine-induced immunity.
Baba K; Tsuda N; Yabuuchi H; Konishi S; Fujinami A; Tsujino G; Takahashi M
Biken J; 1980 Jun; 23(2):89-94. PubMed ID: 6257226
[TBL] [Abstract][Full Text] [Related]
7. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
[TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine.
Kumagai T; Chiba Y; Fujiwara M; Hanazono H; Nakamura S; Chiba S; Nakao T; Takahashi M
Biken J; 1980 Sep; 23(3):135-41. PubMed ID: 6257227
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
[TBL] [Abstract][Full Text] [Related]
10. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
Horiuchi K
Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
[TBL] [Abstract][Full Text] [Related]
12. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
[TBL] [Abstract][Full Text] [Related]
13. Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection.
Asano Y; Yazaki T; Miyata T; Nakayama H; Hirose S
Biken J; 1975 Mar; 18(1):35-40. PubMed ID: 167708
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
[TBL] [Abstract][Full Text] [Related]
15. Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.
Sugino H; Tsukino R; Miyashiro E; Dezawa T; Shinohara K; Uemura S; Koike M
Biken J; 1984 Sep; 27(2-3):63-5. PubMed ID: 6100060
[TBL] [Abstract][Full Text] [Related]
16. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
[TBL] [Abstract][Full Text] [Related]
17. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
Chiba Y; Miura J; Kumagai T; Nakao T
Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
[TBL] [Abstract][Full Text] [Related]
18. Worldwide experience with the Oka-strain live varicella vaccine.
Andre FE
Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
[TBL] [Abstract][Full Text] [Related]
20. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
Ueda K; Tokugawa K; Nakashima F; Takahashi M
Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
